Formulation challenges for 21st century topical and transdermal delivery systems

Topical and cutaneous delivery using nanosystems

(2017) MS Roberts et al.   JOURNAL OF CONTROLLED RELEASE

A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoL

(2016) U. Reinhold et al.   BRITISH JOURNAL OF DERMATOLOGY

Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability

(2016) Yong Chen et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots

(2016) Mayank Singhal et al.   MOLECULAR PHARMACEUTICS

Transdermal patches: history, development and pharmacology

(2015) Michael N Pastore et al.   BRITISH JOURNAL OF PHARMACOLOGY

Future of the transdermal drug delivery market – have we barely touched the surface?

(2015) Adam C. Watkinson et al.   Expert Opinion on Drug Delivery

Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin

(2013) Taís Gratieri et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends

(2013) O. Perumal et al.   SKIN PHARMACOLOGY AND PHYSIOLOGY

MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

(2009) Lorinda Chung et al.   ARTHRITIS AND RHEUMATISM